MCIT Rule Likely Too Broken For CMS To Implement In December, Analyst Predicts
John Leppard with Washington Analysis says the Medicare agency’s recent delay of the MCIT breakthrough devices rule until mid-December suggests the CMS will likely scrap it altogether and start from scratch.
You may also be interested in...
The US Medicare agency has proposed to withdraw a rule that would give temporary automatic coverage to breakthrough devices, stating the rule doesn’t meet its evidence threshold and could put patients at risk.
Cognoa’s Sharief Taraman tells Medtech Insight that artificial intelligence and machine learning can help bring new pediatric diagnostics and treatments to market but it’s important to avoid perpetuating racial, gender and other disparities.
Four US senators are leading a bipartisan effort to bring potentially life-saving medical treatments to Medicare beneficiaries by requiring reimbursement for breakthrough technologies cleared by the FDA.